Preparation and Characterization of Chitosan Coated PLGA Nanoparticles of Resveratrol: Improved Stability, Antioxidant and Apoptotic Activities in H1299 Lung Cancer Cells

被引:60
作者
Aldawsari, Hibah M. [1 ]
Alhakamy, Nabil A. [1 ]
Padder, Rayees [2 ]
Husain, Mohammad [2 ]
Shadab, Md [1 ]
机构
[1] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah 21589, Saudi Arabia
[2] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India
关键词
resveratrol; PLGA nanoparticles; chitosan; coating; apoptosis; cell viability; CYCLE ARREST; BIOAVAILABILITY; FORMULATION; PROTECTION; RELEASE; PATHWAY;
D O I
10.3390/coatings10050439
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Resveratrol (RES) is a polyphenolic compound which has shown beneficial pharmacological effects such as anti-inflammatory, antioxidant, and anti-cancer effects. However, poor aqueous solubility, bioavailability, and low stability are the major limitations to the clinical application of RES. Therefore, in the present study, chitosan (CS) coated PLGA nanoparticles of RES (CS-RES-PLGA NPs) was developed, characterized and its anticancer activity was evaluated in the H1299 lung carcinoma cell line. The effects of the increase in CS coating and cryoprotectant concentration on particle size, polydispersity index (PDI) and zeta potential (ZP) were determined. The particle size, PDI, ZP and entrapment efficiency of the optimized CS-RES-PLGA NPs were found to be 341.56 +/- 7.90 nm, 0.117 +/- 0.01, 26.88 +/- 2.69 mV and 75.13% +/- 1.02% respectively. The average particle size and ZP showed a steady increase with an increase in CS concentration. The increase in positive zeta potential is evident for higher CS concentrations. The effect of trehalose as cryoprotectant on average particle size was decreased significantly (p< 0.05) when it was increased from 1%-5%w/v. TEM and SEM showed uniform particle distribution with a smooth surface and spherical shape. The CS coating provides modulation of in vitro drug release and showed a sustained release pattern. The stability of RES loaded PLGA NPs was improved by CS coating. CS-coated NPs showed greater cytotoxicity and apoptotic activities compared to free RES. The CS coated NPs had a higher antioxidant effect than the free RES. Therefore, CS coated PLGA NPs could be a potential nanocarrier of RES to improve drug solubility, entrapment, sustain release, stability and therapeutic application.
引用
收藏
页数:19
相关论文
共 48 条
  • [1] A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization
    Abdelwahed, W
    Degobert, G
    Fessi, H
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 309 (1-2) : 178 - 188
  • [2] Freeze-drying of nanoparticles: Formulation, process and storage considerations
    Abdelwahed, Wassim
    Degobert, Ghania
    Stainmesse, Serge
    Fessi, Hatem
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) : 1688 - 1713
  • [3] Ahmad N, 2001, CLIN CANCER RES, V7, P1466
  • [4] Surface modification of PLGA nanoparticles using chitosan: Effect of molecular weight, concentration, and degree of deacetylation
    Al-Nemrawi, Nusaiba K.
    Okour, Arren R.
    Dave, Rutesh H.
    [J]. ADVANCES IN POLYMER TECHNOLOGY, 2018, 37 (08) : 3066 - 3075
  • [5] Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis
    Al-Nemrawi, Nusaiba K.
    Alshraiedeh, Nid'' A. H.
    Zayed, Aref L.
    Altaani, Bashar M.
    [J]. PHARMACEUTICALS, 2018, 11 (01)
  • [6] Repurposing Itraconazole Loaded PLGA Nanoparticles for Improved Antitumor Efficacy in Non-Small Cell Lung Cancers
    Alhakamy, Nabil A.
    Md, Shadab
    [J]. PHARMACEUTICS, 2019, 11 (12)
  • [7] Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without hyaluronate or alginate coating
    Almalik, Abdulaziz
    Alradwan, Ibrahim
    Kalam, Mohd Abul
    Alshamsan, Aws
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (06) : 861 - 867
  • [8] Administration of resveratrol: What formulation solutions to bioavailability limitations?
    Amri, A.
    Chaumeil, J. C.
    Sfar, S.
    Charrueau, C.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 158 (02) : 182 - 193
  • [9] MTT assay to evaluate the cytotoxic potential of a drug
    Bahuguna, Ashutosh
    Khan, Imran
    Bajpai, Vivek K.
    Kang, Sun Chul
    [J]. BANGLADESH JOURNAL OF PHARMACOLOGY, 2017, 12 (02) : 115 - 118
  • [10] Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles
    Budhian, Avinash
    Siegel, Steven J.
    Winey, Karen I.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 346 (1-2) : 151 - 159